Non-Alcoholic Fatty Liver Disease (NAFLD) Affects 30-40% of U.S. Adults, Driving Significant Market Need for BioHarvest's Future Olive Cell Product Targeting Liver Health Vancouver, British Columbia ...

In vitro skin irritation testing has emerged as a critical component in the safety evaluation of chemicals and medical devices, aiming to replace traditional animal-based assays. Central to this ...

The global in vitro toxicity testing market is expected to expand at a compound annual growth rate of around 10% during the forecast period, reflecting the increasing need for safer, faster, and more ...

NEW YORK, NY, UNITED STATES, January 30, 2026 /EINPresswire.com/ — Creative Bioarray, one of the leading providers of innovative biological research tools and ...

In a recent webinar, Dr. Lena Smirnova explained how brain microphysiological systems are transforming in vitro neurotoxicity testing and disease modeling. NewsMedical compiled the key highlights in ...

Chicago, Feb. 03, 2026 (GLOBE NEWSWIRE) -- The global in-vitro toxicology testing market was valued at 26.00 billion in 2024 and is expected to reach US$ 57.55 billion by 2033, growing at a CAGR of ...

CFU: Colony-forming unit; CLSI: Clinical Laboratory Standard Institute; EUCAST: European Committee on Antimicrobial Susceptibility Testing; MEC: Minimum effective concentration; MIC: Minimum ...

Addressing for the first time the issue of whether bioequivalence data and in vitro testing can show that an abbreviated new drug application (ANDA) product with different immediate and delayed ...